SPS
LGND icon

Susquehanna Portfolio Strategies’s Ligand Pharmaceuticals LGND Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
8,619
+650
+8% +$153K 0.04% 390
2026
Q1 		$1.59M Buy
7,969
+225
+3% +$44.5K 0.02% 548
2025
Q4 		$1.46M Buy
7,744
+1,947
+34% +$374K 0.02% 570
2025
Q3 		$1.03M Buy
5,797
+4,006
+224% +$596K 0.02% 677
2025
Q2 		$204K Buy
+1,791
New +$191K ﹤0.01% 795

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna Portfolio Strategies's LGND Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Ligand Pharmaceuticals (LGND) stake by 8.2% in Q2 2026, buying an estimated $153K and bringing the position to 8,619 shares worth $2.72M. The position accounts for 0.04% of the portfolio, ranked #390.

Susquehanna Portfolio Strategies first reported a position in LGND in Q2 2025 and has held it in 5 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Susquehanna Portfolio Strategies held 8,619 shares of Ligand Pharmaceuticals worth $2.72M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 650 Ligand Pharmaceuticals shares in Q2 2026, an estimated $153K.
  • Ligand Pharmaceuticals made up 0.04% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #390 holding.
  • Susquehanna Portfolio Strategies first reported a position in Ligand Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.